CLARISSA LORANCE: Open Payments
NPI 1063060143 · BOZEMAN, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$160 in 7 payments from 6 companies in 2025. Trend: 2023 $206 · 2024 $262 · 2025 $160
Food & beverage: $160
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 2 | $49 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Novocure Inc. | 1 | $22 |
| ARGENX US, INC. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: Tecentriq, Enhertu, NINLARO, VYVGART, PLUVICTO.
Industry payments across MT — which companies pay providers there.
